BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bio-PAT - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bio-PAT
X-ORIGINAL-URL:https://bio-pat.org
X-WR-CALDESC:Veranstaltungen für Bio-PAT
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230510T080000
DTEND;TZID=Europe/Paris:20230512T170000
DTSTAMP:20260415T191525
CREATED:20230124T083340Z
LAST-MODIFIED:20230124T083404Z
UID:7287-1683705600-1683910800@bio-pat.org
SUMMARY:Chair of Bioprocess Engineering (TU Berlin) at Pharma 4.0 Global Bioprocessing Summit
DESCRIPTION:Pharma 4.0 Global Bioprocessing Summit in Berlin \n\n\n\n“Where the world’s technology leaders\, scientists and engineers from pharma\, biotech and pharma suppliers get together for commercial progress and successful large-scale bioprocessing.” \n\n\n\nProf. Peter Neubauer of the Chair of Bioprocess Engineering at the Technische Universität Berlin will give a talk as well. Further there will be a lab tour showing the laboratories of the Chair of Bioprocess Engineering on May 10. \n\n\n\nBrochureRegistration \n\n\n\nKEY TRACKS \n\n\n\nDownstream Processing & Continuous Biomanufacturing \n\n\n\nIndustry experts will share their knowledge and we will present and discuss how to optimize technologies and process setups\, manufacturing challenges\, and strategies such as digitalization\, modelling\, automation\, scaling up\, single-use technology\, and securing process continuity. Case studies will also be presented in this track. \n\n\n\nContinuous Biomanufacturing: COGS\, batch definitions and sustainability in continuous biomanufacturingmAbs bioprocessing: pre-treatment of feeds and optimizations of expression levels and purification processesDownstream purification: Removal of empty capsids from full ones for AAVs\, tailor-made ligands as well as more difficult targetsGo Greener: sustainable bioprocesses\, single use vs multiple use materials\, as well as digitalization within bioprocessing and manufacturingModelling\, digitalization and automation: Modelling and simulations as a tool to scale-up processes\n\n\n\nATMP Technologies for Cell & Gene Therapies \n\n\n\nAttend the cell and gene therapy track to learn about the future of cell and gene therapy bioprocessing. The track includes expert talks on the considerations around manufacturing ATMPs\, from closed loop systems for cell therapy to decentralized sites. We also cover the technical aspects of how to optimize AAV manufacturing\, tackling increased demand for viral and non-viral vectors\, and developing the next generation of vectors. \n\n\n\nDon’t miss the talks on workforce\, regulatory landscape\, scale up and supply chain: \n\n\n\nFuture of ATMP manufacturing: process development\, facility designCell and gene therapy manufacturing – what skills are needed for your workforce and how to acquire themUnderstanding the regulatory landscape for cell and gene therapiesThe latest innovations in supply chain technology for cell and gene therapiesDeveloping AAV next generation vectors
URL:https://bio-pat.org/event/chair-of-bioprocess-engineering-tu-berlin-at-pharma-4-0-global-bioprocessing-summit
LOCATION:Venue:  Maritim proArte Hotel\, Friedrichstraße 151 / Dorotheenstraße 65\, Berlin\, 10117\, Deutschland
ATTACH;FMTTYPE=image/png:https://bio-pat.org/wp-content/uploads/2023/01/4.0-Global-Process-Summit.png
END:VEVENT
END:VCALENDAR